If you need more lookups,
subscriptions start at $34 USD/month.
Jyotsna Torne Location
Philadelphia, PA, US
Jyotsna Torne Work
VP, Project Management @ (January 2026 - Present)
Head, Cell Therapy Development, Project and portfolio management and Tech writing @ (April 2024 - January 2026)
Director, Project Management @ (August 2021 - April 2024)
Program Director - Immuno-Oncology @ (June 2020 - August 2021)
Technical Project Manager @ (June 2016 - May 2020)
Project Manager, Meningitis and Sepsis Franchise @ (June 2012 - May 2016)
Group Leader, Drug Product development @ (April 2011 - May 2012)
Senior Research Scientist @ (January 2009 - March 2011)
Assistant Manager – R and D @ (May 2006 - September 2008)
Jyotsna Torne Education
ACMA
BCMAS Certification (Medical Affairs)
2020-2020
The University of Edinburgh
Master of Business Administration (MBA)
2013-2016
Institute Of Chemical Technology
PhD (Pharmaceutics)
Jyotsna Torne Skills
Biopharmaceuticals
Change Management
Design of Experiments
Drug Delivery
Drug Development
End to end drug development
Medical Affairs, Immuno-oncology
Pharmaceutical Industry
Project Management
Technology Transfer
Leadership
HPLC
GMP
Sales
Regulatory Affairs
Validation
Generic Programming
Microsoft Office
V&V
Program Management
Marketing
Pharmaceutics
JavaScript
Vaccines
ANDA
Formulation
Product Development
Pharmacy
Research
GLP
R&D
Sop
Process Simulation
Chemistry
Biochemistry
Customer Service
Microsoft Excel
Jyotsna Torne Summary
Jyotsna Torne, based in Philadelphia, PA, US, is currently a VP, Project Management at Summit Therapeutics, Inc.. Jyotsna Torne brings experience from previous roles at Bristol Myers Squibb, Pfizer and GSK. Jyotsna Torne holds a 2020 - 2020 BCMAS Certification in Medical Affairs @ ACMA. With a robust skill set that includes Biopharmaceuticals, Change Management, Design of Experiments, Drug Delivery, Drug Development and more. Jyotsna Torne has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jyotsna Torne?
Find contact details for 700 million professionals.